What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.89%Below 5Y avg (3.30%)
Annual Rate
CNY 0.44Paid semi-annual
Payout Ratio
139.6%High
Payback Period
27.6 yr
Last Ex-Dividend
Sep 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.88BCNY
432.07M · vs all stocks (USD)
Updated Nov 19, 2026
Trailing P/E
29.96x
vs Household & Personal Products peers
Updated Nov 19, 2026
Revenue (TTM)
1.65BCNY
247.06M · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
5.97%
vs Household & Personal Products peers
Updated Nov 19, 2026
Beta
0.3750x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-54.69%
vs all stocks
Updated Nov 19, 2026
Forward Annual Dividend Yield
2.89%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
2.88BCNY
432.07M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
2.27BCNY
341.22M · vs all stocks (USD)
Updated Nov 19, 2026
Trailing P/E
29.96x
vs Household & Personal Products peers
Updated Nov 19, 2026
Forward P/E
10.39x
vs Household & Personal Products peers
Updated Nov 19, 2026
Price to Sales (TTM)
1.75x
vs Household & Personal Products peers
Updated Nov 19, 2026
Price to Book (MRQ)
1.58x
vs Household & Personal Products peers
Updated Nov 19, 2026
Enterprise to Revenue
1.38x
vs Household & Personal Products peers
Updated Nov 19, 2026
Enterprise to EBITDA
11.19x
vs Household & Personal Products peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 13.02×.Updated Nov 19, 2026
Gross Margin
16.65%
vs Household & Personal Products peers
Updated Nov 19, 2026
Profit Margin
5.97%
vs Household & Personal Products peers
Updated Nov 19, 2026
Operating Margin
8.83%
vs Household & Personal Products peers
Updated Nov 19, 2026
Return on Assets (TTM)
4.16%
vs Household & Personal Products peers
Updated Nov 19, 2026
Return on Equity (TTM)
5.35%
vs Household & Personal Products peers
Updated Nov 19, 2026
Revenue (TTM)
1.65BCNY
247.06M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
9.15CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
3.20%
vs Household & Personal Products peers
Updated Nov 19, 2026
Gross Profit (TTM)
274.64MCNY
41.19M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
174.78MCNY
26.22M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
98.42MCNY
14.76M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-68.90%
vs Household & Personal Products peers
Updated Nov 19, 2026
Operating Cash Flow (TTM)
105.11MCNY
15.77M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
8.24MCNY
1.24M · vs all stocks (USD)
Updated Nov 19, 2026
Forward Annual Dividend Rate
0.4400CNYUpdated Nov 19, 2026
Forward Annual Dividend Yield
2.89%
vs all stocks
Updated Nov 19, 2026
Trailing Annual Dividend Rate
0.5200CNYUpdated Nov 19, 2026
Trailing Annual Dividend Yield
3.41%
vs all stocks
Updated Nov 19, 2026
5-Year Average Dividend Yield
3.30%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
139.62%
vs Household & Personal Products peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 100%.Updated Nov 19, 2026
Revenue
1.68BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.34BCNYFY2025 · Dec 31, 2025
Gross Profit
334.27MCNYFY2025 · Dec 31, 2025
Operating Income
214.57MCNY
32.18M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
241.95MCNYFY2025 · Dec 31, 2025
Income Tax Expense
58.93MCNYFY2025 · Dec 31, 2025
Net Income
183.02MCNYFY2025 · Dec 31, 2025
EBIT
242.40MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
290.27MCNYFY2025 · Dec 31, 2025
Research & Development
21.70MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
40.81MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
12.86MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
11.17MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
454.60KCNYFY2025 · Dec 31, 2025
EPS (Basic)
1.00CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.9900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
183.02MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
183.02MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
183.02MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
230.54MCNYFY2025 · Dec 31, 2025
Free Cash Flow
163.02MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
269.20MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
183.02MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
549.28KCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
52.03MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-5.05MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-67.52MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-784.67MCNYFY2025 · Dec 31, 2025
Sale of Investments
699.81MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-30.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-182.38MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-112.35MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-16.37MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-128.72MCNYFY2025 · Dec 31, 2025
Shares Outstanding
184.89MSharesUpdated Nov 19, 2026
Float Shares
74.32MSharesUpdated Nov 19, 2026
% Held by Insiders
58.91%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
3.15%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
685.14MCNY
102.76M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
3.74CNYUpdated Nov 19, 2026
Total Debt (MRQ)
26.29MCNY
3.94M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
0.0145x
vs Household & Personal Products peers
Updated Nov 19, 2026
Current Ratio (MRQ)
3.90x
vs Household & Personal Products peers
Updated Nov 19, 2026
Book Value per Share (MRQ)
9.88CNYUpdated Nov 19, 2026
Total Assets
2.25BCNY
337.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.37BCNYFY2025 · Dec 31, 2025
Total Liabilities
351.55MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
874.20MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
34.66MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
316.90MCNYFY2025 · Dec 31, 2025
Cash
268.67MCNYFY2025 · Dec 31, 2025
Cash Equivalents
31.56MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
300.23MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
513.70MCNYFY2025 · Dec 31, 2025
Accounts Receivable
289.18MCNYFY2025 · Dec 31, 2025
Inventory
192.06MCNYFY2025 · Dec 31, 2025
Accounts Payable
262.08MCNYFY2025 · Dec 31, 2025
Short-term Debt
5.41MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
45.77KCNYFY2025 · Dec 31, 2025
Long-term Debt
17.46MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
184.89MCNYFY2025 · Dec 31, 2025
Retained Earnings
508.03MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.90BCNY
284.37M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
16.12MCNYFY2025 · Dec 31, 2025
52-Week Low
14.68CNYUpdated Nov 19, 2026
52-Week High
34.64CNYUpdated Nov 19, 2026
52-Week Change
-54.69%
vs all stocks
Updated Nov 19, 2026
Beta
0.3750x
vs all stocks
Updated Nov 19, 2026
50-Day MA
17.07CNYUpdated Nov 19, 2026
200-Day MA
18.82CNYUpdated Nov 19, 2026
Avg 10-Day Volume
2.37MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
4.93MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
0.5200CNYUpdated Nov 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
Near 52W Low With Profitability And FCF
Within 1% of its 52-week low, profitable three years, and capex takes less of its cash flow than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesNear 52W Low With Profitability And FCFLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesNear 52W Low With Profitability And FCFLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesNear 52W Low With Profitability And FCFLow-Leverage Liquidity Configuration